Clough Capital Partners L P Repare Therapeutics Inc. Transaction History

Clough Capital Partners L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$19.66 - $28.11 $4.36 Million - $6.24 Million	-221,879 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$25.71 - $35.24 $3.25 Million - $4.45 Million	-126,400 Reduced 36.29%	221,879 $5.82 Million
Q2 2021 Aug 16, 2021	BUY	$30.1 - $34.85 $728,420 - $843,370	24,200 Added 7.47%	348,279 $10.9 Million
Q1 2021 May 17, 2021	BUY	$25.89 - $44.46 $1.12 Million - $1.92 Million	43,100 Added 15.34%	324,079 $9.95 Million
Q4 2020 Feb 16, 2021	BUY	$23.42 - $39.5 $1.85 Million - $3.13 Million	79,200 Added 39.25%	280,979 $9.64 Million
Q3 2020 Nov 17, 2020	BUY	$21.55 - $33.92 $4.35 Million - $6.84 Million	201,779 New	201,779 $6.21 Million

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $55.4M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.